Alexandria Real Estate Equities shares rise 1.58 percent to $41.05

11 articles · Updated · MarketWatch · Apr 29

The stock snapped a two-day losing streak and outperformed major competitors despite a broadly negative market, with trading volume reaching 3.8 million shares, well above its 50-day average.
Alexandria Real Estate Equities closed 53.48% below its 52-week high of $88.24, achieved on September 19th, while BXP, Healthpeak Properties, and Medical Properties Trust all declined.
The S&P 500 and Dow Jones Industrial Average both fell during the session, highlighting Alexandria's relative strength on a challenging trading day for the broader market.

With revenues falling, how is Alexandria Real Estate outperforming a grim market?

While competitor BXP's occupancy rises, why does ARE project a decline?

Is ARE's stock a bargain trading far below its fair value, or a value trap?

How is Alexandria's 'Megacampus' strategy adapting to the new era of autonomous science?

What is the biggest unrecognized threat facing life science real estate today?

Can the life science lab market truly recover from a 30% vacancy rate?